Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd. is a pharmaceutical company based in Lhoka (Shannan), in the Tibet Autonomous Region of China. The company is registered and operates within the Chinese pharmaceutical sector, and its official corporate website is haisco.com. Public reference data identifies it as a company in Lhoka, China, indicating that its registered base is in the Tibet Autonomous Region rather than in a major coastal pharmaceutical hub. As a pharmaceutical group, Haisco is part of China's broader healthcare and life-sciences industry, a sector that includes drug research and development, manufacturing, and commercialization. The company's Chinese name, 海思科医药集团股份有限公司, reflects its status as a joint-stock pharmaceutical group. Its operations and product portfolio are centered on the Chinese market. Detailed information about the company's founding, ownership structure, product lines, and financial status is limited in the available public reference data. The company maintains an official website at haisco.com, which serves as its primary corporate information channel.

Haisco Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company whose registered base is in Lhoka (Shannan), Tibet Autonomous Region, China. Public reference data identifies the company as being located in Lhoka, China, which places its corporate registration in the Tibet Autonomous Region. The company operates under the Chinese name 海思科医药集团股份有限公司 and maintains an official website at haisco.com. The available public reference data does not specify the company's founding year, founders, or detailed corporate history. What is known is that Haisco is a pharmaceutical group active in China's healthcare and life-sciences sector. As a joint-stock pharmaceutical group, it is structured as a corporate entity within the Chinese pharmaceutical industry. Further details about the company's development, including any major milestones, product launches, or ownership changes, are not documented in the available evidence. The company's official website serves as its primary channel for corporate information.

• 2020

  Haisco warned by Tibet CSRC branch over governance, related-party guarantee disclosure

  The Tibet branch of the CSRC said Haisco had non-standard corporate governance, delayed disclosure of related-party transactions and guarantees, and incomplete insider registration, and issued warning letters recorded in integrity files; reports also said its performance relied heavily on government subsidies. Warning letters.

  Source

Read more

1. 1Haisco Pharmaceutical Group Co., Ltd. (China) - Wikidatawikidata.org
2. 2Haisco warned by Tibet CSRC branch over governance, related-party guarantee disclosurefinance.sina.com.cn